Canada: Targeted Diagnostic Botox Injections Can Identify Trigger Sites for Migraine

Diagnostic targeted Botox injections have high positive predictive value for migraine trigger site localization, according to a study published in the May issue of Plastic and Reconstructive Surgery.

Hassan ElHawary, M.D., from the McGill University Health Centre in Montreal, and colleagues examined the diagnostic capacity of Botox in a sensitivity analysis performed on 40 patients receiving Botox for migraine trigger site localization followed by surgical decompression of affected peripheral nerves.

Source: Advances and More licensed by HealthDay